The
global Minimally
Invasive Surgical Instruments Market size is expected to reach USD 63.0
billion in 2030, registering a CAGR of 10.3% from 2023 to 2030, according to a
new report by Grand View Research, Inc. The preference for minimally invasive
surgical (MIS) procedures is rising as they are less traumatic than traditional
open surgeries and they facilitate faster recover process. Patients can resume
their daily activities in a shorter time after minimally invasive surgical
procedures.
In
addition, the costs involved in MIS procedures are significantly less than
in-patient and conventional open surgeries. Therefore, MIS procedures prove to
be beneficial for patients as well as payers. The benefits of MIS in various
areas of orthopedics have contributed to the growing demand for less traumatic
alternatives with minimum tissue disruption of bones.
Noncommunicable
Diseases (NCDs), often known as chronic diseases, affect more than 41 million
individuals each year, accounting for approximately 74% of all deaths
worldwide. According to the same source, nearly 15 million people aged 30 to 69
die worldwide each year as a result of NCDs. As a result of the high mortality
rate due to NCDs, the need for therapeutic techniques is increasing. Minimally
invasive techniques are gaining traction as they offer more benefits than
regular procedures. As a result, the market under consideration is anticipated
to grow over the forecast period.
Related Press
Release@ Minimally
Invasive Surgical Instruments Market Report
List of Key Players in the Minimally Invasive Surgical
Instruments Market
- Medtronic
- Siemens
- Healthineer
AG
- Ethicon,
Inc. (Johnson & Johnson)
- Depuy
Synthes
- GE
Healthcare
- Abbott
Laboratories
- Intutive
Surgical, Inc.
- Nuvasive,
Inc.
- Zimmer
Biomet
Minimally Invasive Surgical Instruments Market Highlights
- Minimal
invasive technologies are designed to cause less trauma than traditional
open surgeries, reduced blood loss, minimal scarring, and low chances of
infection
- Handheld
instruments dominated the device segment in terms of revenue share in 2022.
On the other hand, electrosurgical devices are expected to witness the
fastest growth rate during the forecast period from 2023 to 2030.
- Orthopedic
segment dominated the application segment in terms of revenue share in
2022. Minimally invasive surgical procedures in various areas of
orthopedics offer surgical alternatives with minimum tissue disruption
- Continuous
adoption of minimally invasive surgical techniques for spine related
procedures has led to the expansion of procedural volumes for orthopedic MIS
- Hospital
segment held most of the end use segment share in 2022. On the other hand,
ambulatory surgically centers are likely to experience fastest growth in
the coming years.
- Ambulatory
surgical centers offer same day surgery and discharge at lower costs.
At present, over 5,500 Medicare certified ambulatory care centers are
present in the U.S.
- North
America held majority of the market share in 2022 due to the presence of
supportive reimbursement framework for innovative MIS devices and
procedures
Minimally Invasive Surgical Instruments
Market Report Scope
|
Report Attribute |
Details |
|
Market
size value in 2023 |
USD 31.6
billion |
|
Revenue
forecast in 2030 |
USD 63.0
billion |
|
Growth
rate |
CAGR of
10.3% from 2023 to 2030 |
|
Base year
for estimation |
2022 |
|
Historical data |
2018 - 2021 |
|
Forecast period |
2023 - 2030 |
Related Reports@
Non Invasive Prenatal Testing Market
Minimally Invasive Thoracic Surgery Market
Minimally Invasive Surgical Instruments Market
Segmentation
Grand
View Research has segmented the minimally invasive surgical instruments market
based on device, application, end-use, and region:
Minimally Invasive Surgical Instruments Device Outlook
(Revenue, USD Million, 2018 - 2030)
- Handheld
Instruments
- Inflation
Devices
- Cutter
Instruments
- Guiding
Devices
- Electrosurgical
Devices
- Auxiliary
Devices
- Monitoring
& Visualization Devices
Minimally Invasive Surgical Instruments Application
Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiac
- Gastrointestinal
- Orthopedic
- Vascular
- Gynecological
- Urological
- Thoracic
- Cosmetic
- Dental
- Others
Minimally Invasive Surgical Instruments End-use Outlook
(Revenue, USD Million, 2018 - 2030)
- Hospitals
& Clinics
- Ambulatory
Surgical Centers
Minimally Invasive Surgical Instruments Regional
Outlook (Revenue, USD Million, 2018 - 2030)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin
America
- Mexico
- Brazil
- Argentina
- Middle East
and Africa (MEA)
- South
Africa
- Saudi
Arabia
- UAE
- Kuwait
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment